Research study Program year 2022 Source: CMS Open Payments

Urogen Bl-006

Research payments

$812,043

507 payments

Through program year 2022, $812,043 in research payments was reported against Urogen Bl-006, across 507 payments, paid by Urogen Pharma, Inc..

Paid by: Urogen Pharma, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$275,374	286
2021	Research	$536,669	221

Breakdown

Who paid Research payments · program years 2021–2022

Urogen Pharma, Inc. $812,043 507 payments

Who received the money Research payments · program years 2021–2022

Manhattan Medical Research Practice, Pllc Organisation paid for research $124,788 69 payments
Morristown Medical Center Teaching hospital · NJ $106,999 70 payments
New Jersey Urology, Llc Organisation paid for research $79,706 35 payments
Carolina Urologic Research Center, LLC Organisation paid for research $67,662 40 payments
Accumed Research Associates Organisation paid for research $60,607 37 payments
Arizona Institute Of Urology, Pllc Organisation paid for research $49,463 25 payments
Urology Center Organisation paid for research $34,365 16 payments
The University Of North Carolina At Chapel Hill Organisation paid for research $32,586 33 payments
Loma Linda University Health Organisation paid for research $28,935 16 payments
Wichita Urology Group, P.A. Organisation paid for research $22,580 10 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.